Home
My Account
About Us
Forum
Contact us
الواجهة العربية
epharmaweb.com
Medical News Medical News
Aricles Articles
Events Events
Guidelines Guidelines
Videos Library Videos Library
Diseases Diseases
Follow us : facebook twitter Digg Linkedin Boxiz
Newsletter

Please select the categories you are intersted in:
News Articles Guidelines Events Videos Journals' abstracts

Latest Subscribers
Advanced Search »



Agenerase

Main

You must sign in to use this servcie


Feedback - Please use the form below to send your query or comment

You must sign in to use this servcie

Username:
Password:

Info

Indications:

HIV infection.

Contraindications:

Hypersensitivity; sulfonamide allergy. Oral solution: Infants, child <4 yr old; renal or hepatic failure; concomitant metronidazole or disulfiram therapy. Pregnancy and lactation.

Adverse reactions:

Tremors, oral or perioral paraesthesia; mood disorders, dyslipidaemia, redistribution of body fat causing "protease paunch", buffalo hump, facial atrophy and breast enlargement; rash; GI effects e.g. nausea, vomiting and diarrhoea. Potentially Fatal: Hypersensitivity, Stevens-Johnson syndrome and acute haemolytic anaemia.

Interactions:

Clorazepate, alprazolam, diazepam, erythromycin and midazolam increase risk of prolonged sedation and respiratory depression. Plasma concentrations of cilostazol, rifabutin, sertindole and terfenadine (risk of ventricular arrhythmias), sildenafil, antiarrhythmics may be increased. May increase warfarin effects. St. John’s wort. Ethanol. Oestrogens; dexamethasone; delavirdine; efavirenz and veriparine; methadone. Potentially Fatal: Drugs with narrow therapeutic index e.g. cisapride and terfenadine, pimozide, guanidine and rifampicin. Ergot alkaloids; lovastatin and simvastatin.

Warnings:

Elderly; renal impairment, hepatic impairment, DM, haemophilia; sensitivity to sulfonamides; use of sildenafil, vitamin E supplements. Always use with other antiretroviral agents in HIV treatment. Use oral solution only when capsule and other protease inhibitors are not therapeutic options. Capsule and oral solution not interchangeable on a mg-per-mg basis. Monitor for propylene glycol-associated adverse effect when oral solution is admin.

Form:

SOLUTION FOR INJECTION

Dosage and Administration

You must sign in to use this servcie

Technical Description

You must sign in to use this servcie






Forgot your password


sign up

Consultants Corner

Yaser Habrawi , F.R.C.S.Ed

Yaser Habrawi , F.R.C.S.Ed Consultant Ophthalmologist

Dr. Samer Al-Jneidy

Dr. Samer Al-Jneidy Pediatrician

Dr. Talal Sabouni

Dr. Talal Sabouni UROLOGY AND KIDNEY TRANSPLANT

Dr . Dirar Abboud

Dr . Dirar Abboud Hepatologist – Gastroenterologist

Dr. Hani Najjar

Dr. Hani Najjar Pediatrics, Neurology

Samir Moussa M.D.

Samir Moussa M.D. ENT Specialist

Dr. Tahsin Martini

Dr. Tahsin Martini Degree status: M.D. in Ophthalmology

Dr. Faisal Dibsi

Dr. Faisal Dibsi Specialist of Otolaryngology - Head and Neck Surgery
Poll

Which of the following you are mostly interested in?

Cancer Research
Mental Health
Heart Disease & Diabetes
Sexual Health
Obesity and Healthy Diets
Mother & Child Health

Disclaimer : This site does not endorse or recommend any medical treatment, pharmaceuticals or brand names. More Details